D. Druzhilovskiy, P. Savosina, O. Gomazkov, B. Sobolev, A. Veselovsky, O. Tarasova, N. Biziukova, N. Ionov, S. Ivanov, A. Rudik, L. Stolbov, P. Pogodin, D. Karasev, D.A. Dmitriev, A. Lagunin, D. Filimonov
{"title":"新冠肺炎治疗药物重新定位","authors":"D. Druzhilovskiy, P. Savosina, O. Gomazkov, B. Sobolev, A. Veselovsky, O. Tarasova, N. Biziukova, N. Ionov, S. Ivanov, A. Rudik, L. Stolbov, P. Pogodin, D. Karasev, D.A. Dmitriev, A. Lagunin, D. Filimonov","doi":"10.37747/2312-640x-2021-19-209-211","DOIUrl":null,"url":null,"abstract":"Drug repositioning – the discovery of new indications for the launched drugs – is the rapid natural response to viral infection SARS-CoV-2/COVID-19. We will consider the current state of research and development of repositioned pharmaceuticals for the therapy of COVID-19 using in silico and in vitro methods.","PeriodicalId":13077,"journal":{"name":"http://eng.biomos.ru/conference/articles.htm","volume":"32 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"DRUG REPOSITIONING FOR THERAPY OF COVID-19\",\"authors\":\"D. Druzhilovskiy, P. Savosina, O. Gomazkov, B. Sobolev, A. Veselovsky, O. Tarasova, N. Biziukova, N. Ionov, S. Ivanov, A. Rudik, L. Stolbov, P. Pogodin, D. Karasev, D.A. Dmitriev, A. Lagunin, D. Filimonov\",\"doi\":\"10.37747/2312-640x-2021-19-209-211\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Drug repositioning – the discovery of new indications for the launched drugs – is the rapid natural response to viral infection SARS-CoV-2/COVID-19. We will consider the current state of research and development of repositioned pharmaceuticals for the therapy of COVID-19 using in silico and in vitro methods.\",\"PeriodicalId\":13077,\"journal\":{\"name\":\"http://eng.biomos.ru/conference/articles.htm\",\"volume\":\"32 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"http://eng.biomos.ru/conference/articles.htm\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37747/2312-640x-2021-19-209-211\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"http://eng.biomos.ru/conference/articles.htm","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37747/2312-640x-2021-19-209-211","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Drug repositioning – the discovery of new indications for the launched drugs – is the rapid natural response to viral infection SARS-CoV-2/COVID-19. We will consider the current state of research and development of repositioned pharmaceuticals for the therapy of COVID-19 using in silico and in vitro methods.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
